Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Tumefactive fibroinflammatory lesion successfully treated with Rituximab.

Bishop JL, Bryan LJ, Savage NM, Byrd JK.

Intractable Rare Dis Res. 2019 May;8(2):138-141. doi: 10.5582/irdr.2019.01061.

2.

PEG10 is associated with treatment-induced neuroendocrine prostate cancer.

Kim S, Thaper D, Bidnur S, Toren P, Akamatsu S, Bishop JL, Colins C, Vahid S, Zoubeidi A.

J Mol Endocrinol. 2019 Jul 1;63(1):39-49. doi: 10.1530/JME-18-0226.

PMID:
31013476
3.

Early Results of Irreversible Electroporation (IRE) for Tumor Ablation in Soft Tissue Tumors.

Walsh N, Jones AJ, Gable JK, Mentzer CJ, Bishop JL, Kruse EJ.

Am Surg. 2018 Nov 1;84(11):e445-e447. No abstract available.

PMID:
30747646
4.

Similarities and differences in antimicrobial prescribing between major city hospitals and regional and remote hospitals in Australia.

Bishop JL, Schulz TR, Kong DCM, James R, Buising KL.

Int J Antimicrob Agents. 2019 Feb;53(2):171-176. doi: 10.1016/j.ijantimicag.2018.10.009. Epub 2018 Oct 26.

PMID:
30722961
5.

Galiellalactone inhibits the STAT3/AR signaling axis and suppresses Enzalutamide-resistant Prostate Cancer.

Thaper D, Vahid S, Kaur R, Kumar S, Nouruzi S, Bishop JL, Johansson M, Zoubeidi A.

Sci Rep. 2018 Nov 23;8(1):17307. doi: 10.1038/s41598-018-35612-z.

6.

Qualitative study of the factors impacting antimicrobial stewardship programme delivery in regional and remote hospitals.

Bishop JL, Schulz TR, Kong DCM, Buising KL.

J Hosp Infect. 2019 Apr;101(4):440-446. doi: 10.1016/j.jhin.2018.09.014. Epub 2018 Sep 27.

PMID:
30267740
7.

Clinical and epidemiological factors associated with suicide in colorectal cancer.

Pham TT, Talukder AM, Walsh NJ, Lawson AG, Jones AJ, Bishop JL, Kruse EJ.

Support Care Cancer. 2019 Feb;27(2):617-621. doi: 10.1007/s00520-018-4354-3. Epub 2018 Jul 20.

PMID:
30027329
8.

Effects of a compression garment on sensory feedback transmission in the human upper limb.

Barss TS, Pearcey GEP, Munro B, Bishop JL, Zehr EP.

J Neurophysiol. 2018 Jul 1;120(1):186-195. doi: 10.1152/jn.00581.2017. Epub 2018 Apr 11.

9.

Response to Tetanus and Pneumococcal Vaccination Following Administration of Ixekizumab in Healthy Participants.

Gomez EV, Bishop JL, Jackson K, Muram TM, Phillips D.

BioDrugs. 2017 Dec;31(6):545-554. doi: 10.1007/s40259-017-0249-y.

10.

Targeting Prostate Cancer Subtype 1 by Forkhead Box M1 Pathway Inhibition.

Ketola K, Munuganti RSN, Davies A, Nip KM, Bishop JL, Zoubeidi A.

Clin Cancer Res. 2017 Nov 15;23(22):6923-6933. doi: 10.1158/1078-0432.CCR-17-0901. Epub 2017 Sep 12.

11.

The Scottish enhanced Staphylococcus aureus bacteraemia surveillance programme: the first 18 months of data in children.

Murdoch F, Danial J, Morris AK, Czarniak E, Bishop JL, Glass E, Imrie LJ.

J Hosp Infect. 2017 Oct;97(2):127-132. doi: 10.1016/j.jhin.2017.06.017. Epub 2017 Jun 20.

PMID:
28645466
12.

The Scottish enhanced Staphylococcus aureus bacteraemia surveillance programme: the first 18 months of data in adults.

Murdoch F, Danial J, Morris AK, Czarniak E, Bishop JL, Glass E, Imrie LJ.

J Hosp Infect. 2017 Oct;97(2):133-139. doi: 10.1016/j.jhin.2017.06.008. Epub 2017 Jun 8.

PMID:
28602702
13.

Targeting Lyn regulates Snail family shuttling and inhibits metastasis.

Thaper D, Vahid S, Nip KM, Moskalev I, Shan X, Frees S, Roberts ME, Ketola K, Harder KW, Gregory-Evans C, Bishop JL, Zoubeidi A.

Oncogene. 2017 Jul 13;36(28):3964-3975. doi: 10.1038/onc.2017.5. Epub 2017 Mar 13.

PMID:
28288135
14.

Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis.

Benzon B, Zhao SG, Haffner MC, Takhar M, Erho N, Yousefi K, Hurley P, Bishop JL, Tosoian J, Ghabili K, Alshalalfa M, Glavaris S, Simons BW, Tran P, Davicioni E, Karnes RJ, Boudadi K, Antonarakis ES, Schaeffer EM, Drake CG, Feng F, Ross AE.

Prostate Cancer Prostatic Dis. 2017 Mar;20(1):28-35. doi: 10.1038/pcan.2016.49. Epub 2016 Nov 1.

15.

The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer.

Bishop JL, Thaper D, Vahid S, Davies A, Ketola K, Kuruma H, Jama R, Nip KM, Angeles A, Johnson F, Wyatt AW, Fazli L, Gleave ME, Lin D, Rubin MA, Collins CC, Wang Y, Beltran H, Zoubeidi A.

Cancer Discov. 2017 Jan;7(1):54-71. doi: 10.1158/2159-8290.CD-15-1263. Epub 2016 Oct 26.

16.

Molecular chaperone Hsp27 regulates the Hippo tumor suppressor pathway in cancer.

Vahid S, Thaper D, Gibson KF, Bishop JL, Zoubeidi A.

Sci Rep. 2016 Aug 24;6:31842. doi: 10.1038/srep31842.

17.

Linkages between mineralogy, fluid chemistry, and microbial communities within hydrothermal chimneys from the Endeavour Segment, Juan de Fuca Ridge.

Lin TJ, Ver Eecke HC, Breves EA, Dyar MD, Jamieson JW, Hannington MD, Dahle H, Bishop JL, Lane MD, Butterfield DA, Kelley DS, Lilley MD, Baross JA, Holden JF.

Geochem Geophys Geosyst. 2016 Feb;17(2):300-323. doi: 10.1002/2015GC006091. Epub 2016 Jan 11.

18.

Regulation of tumor cell plasticity by the androgen receptor in prostate cancer.

Bishop JL, Davies A, Ketola K, Zoubeidi A.

Endocr Relat Cancer. 2015 Jun;22(3):R165-82. doi: 10.1530/ERC-15-0137. Epub 2015 May 1. Review.

PMID:
25934687
19.

Inhibition of the HER2-YB1-AR axis with Lapatinib synergistically enhances Enzalutamide anti-tumor efficacy in castration resistant prostate cancer.

Shiota M, Bishop JL, Takeuchi A, Nip KM, Cordonnier T, Beraldi E, Kuruma H, Gleave ME, Zoubeidi A.

Oncotarget. 2015 Apr 20;6(11):9086-98.

20.

PD-L1 is highly expressed in Enzalutamide resistant prostate cancer.

Bishop JL, Sio A, Angeles A, Roberts ME, Azad AA, Chi KN, Zoubeidi A.

Oncotarget. 2015 Jan 1;6(1):234-42.

21.

Mineralogical analyses of surface sediments in the Antarctic Dry Valleys: coordinated analyses of Raman spectra, reflectance spectra and elemental abundances.

Bishop JL, Englert PA, Patel S, Tirsch D, Roy AJ, Koeberl C, Böttger U, Hanke F, Jaumann R.

Philos Trans A Math Phys Eng Sci. 2014 Dec 13;372(2030). pii: 20140198. doi: 10.1098/rsta.2014.0198.

PMID:
25368345
22.

Beyond immune checkpoint blockade: new approaches to targeting host-tumor interactions in prostate cancer: report from the 2014 Coffey-Holden prostate cancer academy meeting.

Miyahira AK, Kissick HT, Bishop JL, Takeda DY, Barbieri CE, Simons JW, Pienta KJ, Soule HR.

Prostate. 2015 Mar 1;75(4):337-47. doi: 10.1002/pros.22920. Epub 2014 Oct 30. Review.

PMID:
25358693
23.

Lyn deficiency leads to increased microbiota-dependent intestinal inflammation and susceptibility to enteric pathogens.

Roberts ME, Bishop JL, Fan X, Beer JL, Kum WW, Krebs DL, Huang M, Gill N, Priatel JJ, Finlay BB, Harder KW.

J Immunol. 2014 Nov 15;193(10):5249-63. doi: 10.4049/jimmunol.1302832. Epub 2014 Oct 22.

24.

Lyn tyrosine kinase regulates androgen receptor expression and activity in castrate-resistant prostate cancer.

Zardan A, Nip KM, Thaper D, Toren P, Vahid S, Beraldi E, Fazli L, Lamoureux F, Gust KM, Cox ME, Bishop JL, Zoubeidi A.

Oncogenesis. 2014 Aug 18;3:e115. doi: 10.1038/oncsis.2014.30.

25.

Hsp27 regulates EGF/β-catenin mediated epithelial to mesenchymal transition in prostate cancer.

Cordonnier T, Bishop JL, Shiota M, Nip KM, Thaper D, Vahid S, Heroux D, Gleave M, Zoubeidi A.

Int J Cancer. 2015 Mar 15;136(6):E496-507. doi: 10.1002/ijc.29122. Epub 2014 Dec 4.

26.

The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer.

Bishop JL, Thaper D, Zoubeidi A.

Cancers (Basel). 2014 Apr 9;6(2):829-59. doi: 10.3390/cancers6020829.

27.

Lyn activity protects mice from DSS colitis and regulates the production of IL-22 from innate lymphoid cells.

Bishop JL, Roberts ME, Beer JL, Huang M, Chehal MK, Fan X, Fouser LA, Ma HL, Bacani JT, Harder KW.

Mucosal Immunol. 2014 Mar;7(2):405-16. doi: 10.1038/mi.2013.60. Epub 2013 Sep 18.

PMID:
24045577
28.

Hsp27 regulates epithelial mesenchymal transition, metastasis, and circulating tumor cells in prostate cancer.

Shiota M, Bishop JL, Nip KM, Zardan A, Takeuchi A, Cordonnier T, Beraldi E, Bazov J, Fazli L, Chi K, Gleave M, Zoubeidi A.

Cancer Res. 2013 May 15;73(10):3109-19. doi: 10.1158/0008-5472.CAN-12-3979. Epub 2013 Mar 14.

29.

The use of Complementary and Alternative Medicine in pregnancy: data from the Avon Longitudinal Study of Parents and Children (ALSPAC).

Bishop JL, Northstone K, Green JR, Thompson EA.

Complement Ther Med. 2011 Dec;19(6):303-10. doi: 10.1016/j.ctim.2011.08.005. Epub 2011 Sep 14.

PMID:
22036522
30.

Salmonella phage ST64B encodes a member of the SseK/NleB effector family.

Brown NF, Coombes BK, Bishop JL, Wickham ME, Lowden MJ, Gal-Mor O, Goode DL, Boyle EC, Sanderson KL, Finlay BB.

PLoS One. 2011 Mar 18;6(3):e17824. doi: 10.1371/journal.pone.0017824.

31.

The Mawrth Vallis region of Mars: A potential landing site for the Mars Science Laboratory (MSL) mission.

Michalski JR, Jean-PierreBibring, Poulet F, Loizeau D, Mangold N, Dobrea EN, Bishop JL, Wray JJ, McKeown NK, Parente M, Hauber E, Altieri F, Carrozzo FG, Niles PB.

Astrobiology. 2010 Sep;10(7):687-703. doi: 10.1089/ast.2010.0491.

PMID:
20950170
32.

Parental accounts of the prevalence, causes and treatments of limb pain in children aged 5 to 13 years: a longitudinal cohort study.

Bishop JL, Northstone K, Emmett PM, Golding J.

Arch Dis Child. 2012 Jan;97(1):52-3. doi: 10.1136/adc.2009.181149. Epub 2010 Sep 30.

PMID:
20889451
33.

Noachian and more recent phyllosilicates in impact craters on Mars.

Fairén AG, Chevrier V, Abramov O, Marzo GA, Gavin P, Davila AF, Tornabene LL, Bishop JL, Roush TL, Gross C, Kneissl T, Uceda ER, Dohm JM, Schulze-Makuch D, Rodríguez JA, Amils R, McKay CP.

Proc Natl Acad Sci U S A. 2010 Jul 6;107(27):12095-100. doi: 10.1073/pnas.1002889107. Epub 2010 Jul 6.

34.

The use of homeopathic products in childhood: data generated over 8.5 years from the Avon Longitudinal Study of Parents and Children (ALSPAC).

Thompson EA, Bishop JL, Northstone K.

J Altern Complement Med. 2010 Jan;16(1):69-79. doi: 10.1089/acm.2009.0007.

PMID:
20105063
35.

Key scientific questions and key investigations from the first international conference on Martian phyllosilicates.

Poulet F, Beaty DW, Bibring JP, Bish D, Bishop JL, Noe Dobrea E, Mustard JF, Petit S, Roach LH.

Astrobiology. 2009 Apr;9(3):257-67. doi: 10.1089/ast.2009.0335.

PMID:
19400732
36.

The impact and recovery of asteroid 2008 TC(3).

Jenniskens P, Shaddad MH, Numan D, Elsir S, Kudoda AM, Zolensky ME, Le L, Robinson GA, Friedrich JM, Rumble D, Steele A, Chesley SR, Fitzsimmons A, Duddy S, Hsieh HH, Ramsay G, Brown PG, Edwards WN, Tagliaferri E, Boslough MB, Spalding RE, Dantowitz R, Kozubal M, Pravec P, Borovicka J, Charvat Z, Vaubaillon J, Kuiper J, Albers J, Bishop JL, Mancinelli RL, Sandford SA, Milam SN, Nuevo M, Worden SP.

Nature. 2009 Mar 26;458(7237):485-8. doi: 10.1038/nature07920.

PMID:
19325630
37.

Orbital identification of carbonate-bearing rocks on Mars.

Ehlmann BL, Mustard JF, Murchie SL, Poulet F, Bishop JL, Brown AJ, Calvin WM, Clark RN, Marais DJ, Milliken RE, Roach LH, Roush TL, Swayze GA, Wray JJ.

Science. 2008 Dec 19;322(5909):1828-32. doi: 10.1126/science.1164759.

38.

Mechanisms of traumatic rupture of the aorta and associated peri-isthmic motion and deformation.

Hardy WN, Shah CS, Mason MJ, Kopacz JM, Yang KH, King AI, Van Ee CA, Bishop JL, Banglmaier RF, Bey MJ, Morgan RM, Digges KH.

Stapp Car Crash J. 2008 Nov;52:233-65.

PMID:
19085165
39.

Glenoid inclination: in vivo measures in rotator cuff tear patients and associations with superior glenohumeral joint translation.

Bishop JL, Kline SK, Aalderink KJ, Zauel R, Bey MJ.

J Shoulder Elbow Surg. 2009 Mar-Apr;18(2):231-6. doi: 10.1016/j.jse.2008.08.002. Epub 2008 Dec 5.

40.

Phyllosilicate diversity and past aqueous activity revealed at Mawrth Vallis, Mars.

Bishop JL, Dobrea EZ, McKeown NK, Parente M, Ehlmann BL, Michalski JR, Milliken RE, Poulet F, Swayze GA, Mustard JF, Murchie SL, Bibring JP.

Science. 2008 Aug 8;321(5890):830-3. doi: 10.1126/science.1159699.

41.

The inositol phosphatase SHIP controls Salmonella enterica serovar Typhimurium infection in vivo.

Bishop JL, Sly LM, Krystal G, Finlay BB.

Infect Immun. 2008 Jul;76(7):2913-22. doi: 10.1128/IAI.01596-07. Epub 2008 Apr 21.

42.

Vinorelbine and infusional 5-fluorouracil in anthracycline and taxane pre-treated metastatic breast cancer.

Stuart NS, McIllmurray MB, Bishop JL, Johnston SR, Price CG, O'Reilly SM, Joffe JK, Neave F, Whipp EC.

Clin Oncol (R Coll Radiol). 2008 Mar;20(2):152-6.

PMID:
18083354
43.

Cancer, cardiovascular disease and diabetes mortality among women with a history of endometrial cancer.

Wild SH, Bryden JR, Lee RJ, Bishop JL, Finlayson AR, Byrne CD, Brewster DH.

Br J Cancer. 2007 Jun 4;96(11):1747-9. Epub 2007 Apr 24.

44.

Deception point: peptidoglycan modification as a means of immune evasion.

Bishop JL, Boyle EC, Finlay BB.

Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):691-2. Epub 2007 Jan 12. No abstract available.

45.

Salmonella: from pathogenesis to therapeutics.

Boyle EC, Bishop JL, Grassl GA, Finlay BB.

J Bacteriol. 2007 Mar;189(5):1489-95. Epub 2006 Dec 22. Review. No abstract available.

46.

SseL is a salmonella-specific translocated effector integrated into the SsrB-controlled salmonella pathogenicity island 2 type III secretion system.

Coombes BK, Lowden MJ, Bishop JL, Wickham ME, Brown NF, Duong N, Osborne S, Gal-Mor O, Finlay BB.

Infect Immun. 2007 Feb;75(2):574-80. Epub 2006 Dec 11.

47.

Friend or foe? Antimicrobial peptides trigger pathogen virulence.

Bishop JL, Finlay BB.

Trends Mol Med. 2006 Jan;12(1):3-6. Epub 2005 Nov 17.

PMID:
16298161
48.

Biogeological Raman spectroscopic studies of Antarctic lacustrine sediments.

Moody CD, Jorge Villar SE, Edwards HG, Hodgson DA, Doran PT, Bishop JL.

Spectrochim Acta A Mol Biomol Spectrosc. 2005 Aug;61(10):2413-7.

PMID:
15876550
49.

Rejected bullies or popular leaders? The social relations of aggressive subtypes of rural african american early adolescents.

Farmer TW, Estell DB, Bishop JL, O'Neal KK, Cairns BD.

Dev Psychol. 2003 Nov;39(6):992-1004.

PMID:
14584980
50.

Supplemental Content

Loading ...
Support Center